JPM
JPMorgan Chase & Co.
JPM's outlook is improving, though it still trails on the overall score.
RGA
Reinsurance Group of America, Incorporated
RGA has the edge over JPM overall, supported by stronger valuation and stronger fundamentals.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
RGA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| N/A | |
| N/A |
RGA's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like RGA.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM has the edge over RGA in the historical PE scenario, which offers more potential upside but is not a forecast.
RGA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 9.1x | $274 | — |
| Cheap | 11x | $272 | -0.6% |
| Current | 11x | $274 | — |
| Fair | 14x | $353 | +29% |
| Expensive | 18x | $454 | +66% |
Historical ranges are pointers, not guarantees.
RGA's PE is in its cheap range at 11x. If earnings grow as analysts expect, today's price would be 9.1x next year's earnings.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
RGA Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
RGA has the edge over JPM on the outlook, with more favorable valuation expectations.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM's earnings per share have climbed steadily: $23.85 over the past year, up 18% from the year before, and higher year over year for 15 quarters in a row.
RGA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $30.01 | +16% |
| Q3 2026 | $25.88 | +99% |
| Q2 2026 | $22.77 | +98% |
| Q1 2026 | $18.46 | +56% |
| Q4 2025 | $17.75 | +65% |
| Q3 2025 | $13.00 | +19% |
| Q2 2025 | $11.52 | -10% |
| Q1 2025 | $11.85 | -7.9% |
| Q4 2024 | $10.74 | -20% |
RGA earned $25.88 per share over the past year, up 99% from the year before.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over RGA on profitability, with a higher operating margin.
RGA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $7.6B | +22% |
| Q2 2026 | $6.6B | +19% |
| Q1 2026 | $6.5B | +23% |
| Q4 2025 | $6.6B | +27% |
| Q3 2025 | $6.2B | +9.8% |
| Q2 2025 | $5.6B | +15% |
| Q1 2025 | $5.3B | -17% |
| Q4 2024 | $5.2B | +4.7% |
RGA has the edge over JPM on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.3% | +3.1 points |
| Q2 2026 | 9.1% | +3 points |
| Q1 2026 | 6.8% | -0.2 points |
| Q4 2025 | 7.7% | +3.4 points |
| Q3 2025 | 5.2% | +1.4 points |
| Q2 2025 | 6.1% | +0.6 points |
| Q1 2025 | 7% | +2.7 points |
| Q4 2024 | 4.3% | +1 points |
RGA's operating margin was 8.3% last quarter, up 3.1 points from the same quarter a year ago.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
RGA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.4B | -$365M |
| Q2 2026 | -$484M | +$336M |
| Q1 2026 | -$2.9B | -$1.4B |
| Q4 2025 | $7.3B | -57% |
| Q3 2025 | -$990M | +$77M |
| Q2 2025 | -$820M | +$147M |
| Q1 2025 | -$1.4B | +$4.3B |
| Q4 2024 | $17.1B | +150% |
RGA has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over RGA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
RGA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | -1.5% | -1M shares |
| 3 years | -1.5% | -1M shares |
| 5 years | -2.9% | -2M shares |
| Available history | +3.3% | +2.1M shares |
RGA has 66M diluted shares, down 1.5% from a year ago, with $289M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $82M |
| Q2 2026 | $52M |
| Q1 2026 | $94M |
| Q4 2025 | $61M |
| Q3 2025 | $75M |
| Q2 2025 | — |
| Q1 2025 | $38M |
| Q4 2024 | $1M |
RGA spent $289M buying back its own shares over the past year, up 154% from the year before.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
RGA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2021 | 0.5x | Very low |
| Q4 2020 | 0.3x | Very low |
| Q3 2020 | 0.4x | Very low |
| Q2 2020 | -0.9x | Net Cash |
| Q1 2020 | 0.2x | Very low |
| Q4 2019 | 1.3x | Healthy |
RGA's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like RGA.
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
RGA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 73.2 | Overbought |
| Stochastic | 81.8 | Overbought |
RGA's weekly RSI is 73 (overbought) and its Stochastic is 82 (overbought).
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
RGA PE vs Financial Services Sector
| Metric | RGA | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 13x | 19% below |
| PE % | 17 | 63 | 46 pts below |
RGA has the edge over JPM on valuation relative to its sector.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM's trend is mixed: it's above four of its five weekly moving averages, and 45% above its 200-week average.
RGA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $260.6 | 5% above |
| 20 week MA | $249.4 | 9.8% above |
| 50 week MA | $224.0 | 22% above |
| 100 week MA | $210.2 | 30% above |
| 200 week MA | $191.9 | 43% above |
RGA has the edge over JPM on trend strength, trading above more of its moving averages.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.
RGA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $162.0 | $113.6 | -30% |
| 2021 | $113.6 | $109.4 | -3.6% |
| 2022 | $109.4 | $142.7 | +30% |
| 2023 | $142.7 | $161.8 | +13% |
| 2024 | $161.8 | $211.4 | +31% |
| 2025 | $211.4 | $205.6 | -2.8% |
| 2026 YTD | $205.6 | $273.7 | +33% |
RGA has the edge over JPM on returns for 2026, with the stronger performance.